tirzepatide shortage fda update list Lilly's No Longer on Drug fda glp 1 shortage list – FDA Announced Removal of Tirzepatide

Gao K, Henning SM, Niu Y, Youssefian AA, Seeram NP, Xu A, Heber D

June 1, 2026: More Cases Join MDL as Eli Lilly Asks for Dismissal of Mounjaro Lawsuits As of June 1, 2026, there are 3,763 active lawsuits in the GLP-1 MDL for gastric injuries

If the 2.4 mg weekly dose causes intolerance, healthcare providers often reduce it to 1.7 mg weekly for up to 4 weeks before attempting to increase again

She also confirmed that there will be teams distributed globally

Ensuring consistency with your injection location and rotating sites as directed by your healthcare provider can help maintain stable effects of the medication